Vector Laboratories Acquires Quanta BioDesign
June 17, 2023
Vector Laboratories has acquired Quanta BioDesign, the inventor of discrete polyethylene glycol (dPEG) technology, expanding Vector's bioconjugation linkers, dyes and payload delivery capabilities. The Plain City, Ohio-based company's dPEG reagents will broaden Vector's product portfolio and support life science and biopharma customers in therapeutic, diagnostic and research applications.
- Buyers
- Vector Laboratories
- Targets
- Quanta BioDesign
- Industry
- Biotechnology
- Location
- Ohio, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.